美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Novo Nordisk A/S B Shares ADRhedged

23.74

+0.79293.45%

成交量：657

成交額：1.54萬

市值：403.63萬

市盈率：- -

高：23.77

開：23.15

低：23.15

收：22.95

52周最高：34.36

52周最低：19.00

股本：17.00萬

流通股本：17.00萬

量比：0.97

換手率：0.39%

股息：1.56

股息率：6.56%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

香港「兩倍做多」改"靈活槓桿"引質疑：就算正股回到高位，曾經的2被做多產品怕是再也回不去了

ETF日報 | 2倍做多Unity Software ETF漲逾31%；2倍做多彭博原油ETF升逾5%

BMO將諾和諾德目標價從45美元上調至47美元。

諾和諾德中國發布首份可持續發展案例集

諾和諾德公司：董事會成員、高管及關聯人士買賣諾和諾德公司股票。

「藥王」禮來替爾泊肽上半年大賣277億美元！諾和諾德也靠減重藥扛起大旗

红星资本局

從GLP-1先行者到被禮來反超，諾和諾德如何一步步丟掉減重藥領先優勢

老虎资讯综合

金錢語錄：諾和諾德CEO談併購

美銀首席執行官：公司每年為員工支出2.5億美元用於報銷GLP-1減重藥物

环球市场播报

相差百億美元！全球第一大藥王與第二大藥王銷售差距在拉大

二季度利潤亮眼股價卻下跌近6% 口服減重藥能撐起諾和諾德的中長期預期嗎？

每日经济新闻

諾和諾德：海牙法院針對 Ceban 下達臨時禁令。

諾和諾德贏得荷蘭法院禁令，保護患者免受未經批准的非法複方司美格魯肽鼻噴霧劑的侵害。

國產藥加速追趕減重明星賽道進入「群雄逐鹿」時代

諾和諾德首席執行官：相較於注射劑，口服版 Wegovy 的市場需求之高，讓我們愈發感到意外。

諾和諾德股價下跌6.8%，觸及盤中低點。

諾和諾德：目前美國市場索馬魯肽注射劑Wegovy的價格走勢與我們年初啓動定價時一致。

諾和諾德首席財務官表示：我們推進全公司轉型以實現80億丹麥克朗成本節約目標的進度，目前已超前於計劃。

諾和諾德股價跌勢擴大，目前跌幅已超5%，年初至今累計下跌10%。

諾和諾德(NVO.US)首席執行官：我們將在資本市場日上詳細介紹如何加速早期資產和早期科學的推進。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/NVOH/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":23.7429,"timestamp":1789675200000,"preClose":22.95,"halted":0,"volume":657,"delay":0,"changeRate":0.034549019607843116,"floatShares":170001,"shares":170001,"eps":0,"marketStatus":"盤前交易","change":0.7929,"latestTime":"09-18 05:57:51 EDT","open":23.15,"high":23.765,"low":23.15,"amount":15430,"amplitude":0.026797,"askPrice":37.75,"askSize":100,"bidPrice":9.5,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":23.7429,"nav":22.814512,"aum":3878489.854512,"dividendRate":0.065632,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.765,"preClose":23.7429,"latestTime":"16:15 EDT","volume":8,"amount":189.9432,"timestamp":1789676100260,"change":0.0221,"changeRate":0.000931,"amplitude":0},"volumeRatio":0.9687409844053934,"impliedVol":0.2452,"impliedVolPercentile":0.5897},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":170001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9687409844053934,"shares":170001,"dividePrice":1.5583,"high":23.765,"amplitude":0.026797,"preClose":22.95,"low":23.15,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":23.7429,"committee":0.333333,"eps":0,"divideRate":0.065632,"volume":657,"delay":0,"ttmEps":0,"open":23.15,"prevYearClose":27.4362,"prevWeekClose":23.4261,"prevMonthClose":24.5859,"prevQuarterClose":26.0576,"fiveDayClose":23.954,"twentyDayClose":25.0553,"sixtyDayClose":25.8826},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-09-16","symbol":"NVOH","amount":0.02979,"announcedDate":"2026-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-16","defaultRemindTime":1789565400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-16","currency":"USD","dateTimestamp":1789531200000,"payDate":"2026-09-23"},{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"},{"executeDate":"2026-09-16","recordDate":"2026-09-16","paymentDate":"2026-09-23","value":0.02979,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657695751","title":"香港「兩倍做多」改\"靈活槓桿\"引質疑：就算正股回到高位，曾經的2被做多產品怕是再也回不去了","url":"https://stock-news.laohu8.com/highlight/detail?id=2657695751","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657695751?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 12:03","pubTimestamp":1786075403,"startTime":"0","endTime":"0","summary":"8月7日，韩国股市7月份经历大跌，SK海力士、三星电子等遭遇大幅回撤。面对个股杠杆产品规模急剧扩张及市场剧烈波动，香港证监会宣布调整监管框架。尽管监管部门强调风险控制，但市场对于\"灵活杠杆\"机制仍存在不少质疑。更有人直呼：就算海力士正股回到高位，这只曾经的2被做多产品怕是再也回不去了！","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/08/07120358041514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SH","SPYH","YSPY","RGTC","SPXL","MMAX","LITC","ETNG","SDS","NVOH","ALA","NBIC","SPXS","COZX","SPY","MVV","TEUP","SPYM","BK4007","SPUU","NVOX","SSO","VRC","IVV","XW","UPRO","SIMX","SPXU","SAA","SPYU","SPYQ","OSSL","VOO","ONTX","SMAX","NVTC","DMAX","HIBL","SPDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127820441","title":"ETF日報 | 2倍做多Unity Software ETF漲逾31%；2倍做多彭博原油ETF升逾5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127820441","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127820441?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 04:06","pubTimestamp":1786046792,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5Amana Developing World ETF上涨1.16%。Tradr 2X Long U Daily ETF上涨31.08%。Leverage Shares 2X Long MTSI Daily ETF上涨29.92%。该产品两倍做多射频与光通信芯片公司MACOM Technology Solutions，底层公司股价走强，杠杆机制放大当日涨幅。Tradr 2X Short NBIS Daily ETF上涨27.00%。2倍做多Figma ETF-Leverage Shares下跌29.90%。GraniteShares 2x Long NBIS Daily ETF下跌26.50%。纳指三倍做空ETF上涨1.07%。大宗商品ETF涨幅Top 5二倍做多彭博原油ETF上涨5.36%。行业指数ETF涨幅Top 5二倍做多能源ETF-Direxion上涨2.70%。债券ETF涨幅Top 5Invesco Senior Loan ETF上涨0.10%。Invesco Ultra Short Duration ETF上涨0.04%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERX","DRIP","DOG","OILU","UCO","SPY","LITC","DGZ","MVV","AAAU","82823","FGDL","RWM","PXJ","LU0531971165.HKD","LU0329931173.USD","TQQQ","FXP","HERO","LU1861558580.USD","SDOW","USE","DIG","OILT","IVV","DZZ","CHAU","SMDD","QQQX","XPP","SPXU","FLBR","FNGD","UGA","UDOW","UWM","DXD","LU0823431563.USD","02843","QQQ","WTIU","82843","ASHR","BK4097","MINT","NBIG","NVTC","FLCH","NOCT","BK4007","DRV","FNGZ","SCO","SPXL","NERD","159945","DDG","BGLD","DIA","VOO","DGP","RGTC","SPYM","URA3","BAR","DBO","SMAX","YSPY","UGL","ONTX","DULL","LU1861559042.SGD","SMN","COZX","SPYU","QQQM","DMAX","02823","BK7084","USL","SGOL","OUNZ","PSQ","TQQY","BK4609","BK4023","BK4077","SPXS","YINN","BK4550","IAU","LU0329931090.USD","BK4588","GLD","USG","TNA","TZA","OILK","YXI","CWEB","SPYH","OIH","SRS","KWEB","SPDN","IXC","QDEC","BIL","SMTG","IAUM","NRGZ","ASHS","VRC","BK4570","TEUP","YGLD","OSSL","GLDM","TWM","GSY","USO","VDE","SSO","IEO","NJUL","BK4593","82822","QMAR","ALA","BKLN","FDN","SRTY","XOP","HIBL","XW","NJAN","URTY","SPYQ","LU0823431647.USD","PXE","SPUU","BK4554","GLDY","MMAX","FIGG","SDS","FAAR","NBIC","FBZ","XES","USFR","YANG","BNO","NVOX","IGLD","OILD","XLE","02822","SAA","SIMX","GUSH","NAPR","DWT","IAUI","IWM","SH","HIBS","BK4585","AMEM","GPIQ","DDM","MTSG","UPRO","SQQQ","APPC","GLL","APPX","DBE","USOI","ETNG","VTWO","DBC","KGLD","WTID","QLD","DRLL","QID","DUG","LU0950373646.USD","NVOH","FTXN","SHNY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2657655680","title":"BMO將諾和諾德目標價從45美元上調至47美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657655680","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657655680?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 18:53","pubTimestamp":1786013632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","BK4599","BK4588","OZEM","NVOX","BK4532","THNR","BK4007","NVO","PPH","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0154236417.USD","BK4585","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657685740","title":"諾和諾德中國發布首份可持續發展案例集","url":"https://stock-news.laohu8.com/highlight/detail?id=2657685740","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657685740?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 16:21","pubTimestamp":1786004498,"startTime":"0","endTime":"0","summary":"北京商报讯（记者卓洋）8月6日，诺和诺德中国在北京正式发布《诺言必践——诺和诺德中国2026可持续发展案例集》，并举行了以“诺言必践，和合共生”为主题的发布活动。这是诺和诺德在华发布的首份可持续发展案例集，从创新关怀、协作可及、绿色运营、社会共益四个维度，通过十个真实案例将公司在可持续发展领域取得的积极进展具象化呈现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608063833863713.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608063833863713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0154236417.USD","THNR","BK4599","PPH","IE00BKVL7J92.USD","NVOX","LU1093756168.USD","BK4585","LU1093756325.SGD","NVO","NVOH","IE00BZ1G4Q59.USD","BK4007","OZEM","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657884226","title":"諾和諾德公司：董事會成員、高管及關聯人士買賣諾和諾德公司股票。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657884226","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657884226?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 15:18","pubTimestamp":1786000709,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","LU1093756325.SGD","OZEM","NVOH","BK4532","BK4585","LU1093756168.USD","BK4007","PPH","THNR","NVOX","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0154236417.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657500501","title":"「藥王」禮來替爾泊肽上半年大賣277億美元！諾和諾德也靠減重藥扛起大旗","url":"https://stock-news.laohu8.com/highlight/detail?id=2657500501","media":"红星资本局","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657500501?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 14:28","pubTimestamp":1785997710,"startTime":"0","endTime":"0","summary":"红星资本局8月6日消息，8月5日晚，美国制药公司礼来（LLY.N）发布了2026年二季报，受其GLP-1/GIP双靶点减重降糖药物替尔泊肽销量增长的推动，公司第二季度营收达到229.74亿美元，同比增长48%；上半年总营收为427.73亿美元，同比增长49%。其中，替尔泊肽贡献了约65%的营收，上半年总收入为276.93亿美元，同比增长88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608063833799834.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608063833799834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4534","AGNG","LU0238689110.USD","IE00B4R5TH58.HKD","LU0471298694.HKD","LU2360106947.USD","LU2168564222.USD","LU2361044949.HKD","NVOH","LU0820561909.HKD","LU0820562030.AUD","LU2111349929.HKD","IE00BZ1G4Q59.USD","LU1720051108.HKD","LU1712237335.SGD","BK4585","LU1035775433.USD","IE00B7KXQ091.USD","LU0353189680.USD","LU2236285917.USD","LU2089283258.USD","LU0210536198.USD","LU0882574139.USD","CANC","LU2361044865.SGD","LU0061475181.USD","SG9999015952.SGD","LU2750360997.AUD","ELIL","BK4588","IE00BWXC8680.SGD","LU1868836757.USD","LU1868837136.USD","LU2237443978.SGD","LU0786609619.USD","LU2237443895.HKD","MEDI","LU2491050154.USD","LU1061106388.HKD","LU0466842654.USD","IE0009355771.USD","JDOC","LU2471134523.USD","RXL","LU0823416689.USD","IE00BJJMRZ35.SGD","IYH","SG9999015986.USD","LU0096364046.USD","LU1291159041.SGD","LU2750360641.GBP","HRTS","LU0354030438.USD","LU2552382215.SGD","LU2756315318.SGD","IE00B1XK9C88.USD","LU0882574055.USD","LU2461242641.AUD","SG9999014914.USD","SG9999015945.SGD","LU0289739699.SGD","LU1127390331.HKD","WDNA","LU0345770308.USD","LU2756315664.SGD","BK4599","LU1069344957.HKD","LU1267930730.SGD","SG9999001176.USD","IE0005OL40V9.USD","NVO","LU0889565916.HKD","LU2023251221.USD","LU0154236417.USD","LU0471298777.SGD","LU0708995401.HKD","PJP","IE00BFSS8Q28.SGD","LU0672654240.SGD","LU1983299246.USD","LU0203201768.USD","LU0417517546.SGD","IE00BK4W5M84.HKD","LLII","IE0004445239.USD","LU0106261372.USD","FHLC","LU0320765992.SGD","LU2106854487.HKD","LU0354030511.USD","LU2213496289.HKD","LU2168564149.EUR","SGXZ81514606.USD","IE00BJJMRX11.SGD","LU2746668974.SGD","SG9999014898.SGD","SGXZ99366536.SGD","LU0158827948.USD","LU1093756325.SGD","IE00BFSS7M15.SGD","LU2089284900.SGD","LU1629891620.HKD","SG9999014880.SGD","LU2746668461.USD","IE00BJT1NW94.SGD","LU2168564065.EUR","TRUH","LU1548497426.USD","LU2471134879.HKD","BK4516","XLV","LU2324357040.USD","LU2237443549.SGD","LU0640476718.USD","LU2602419157.SGD","LU0133085943.USD","MEDX","PPH","LU2112291526.USD","IE0004445015.USD","LU0006306889.USD","GDOC","LU1720051017.SGD","LU2471134952.CNY","IE00BJLML261.HKD","LU0323591593.USD","IHE","CURE","LU0316494557.USD","LU2237443382.USD","LU2552382058.USD","IE00BKVL7J92.USD","IE00BN29S564.USD","LU1145028129.USD","LU0256863811.USD","LU1814569148.SGD","IE00B2B36J28.USD","IE00B4JS1V06.HKD","LU0256863902.USD","LU0353189763.USD","LU1093756168.USD","LU0432979614.USD","LU2468319806.SGD","SG9999015978.USD","LU2023250330.USD","LU2265009873.SGD","LU2357305700.SGD","LU1551013342.USD","VHT","LU2028103732.USD","SGXZ51526630.SGD","SG9999018857.SGD","LU2168563687.JPY","LU2491049909.HKD","MHIP","LU0964807845.USD","IE00BKDWB100.SGD","BK4007","ILDR","LU2063271972.USD","LU2108987350.USD","LU0385154629.USD","LU2417539215.USD","LU1974910355.USD","LU0097036916.USD","LU2237443622.USD","LU2087625088.SGD","LU2491050071.SGD","LU2023250504.SGD","LU2271345857.HKD","LU2462157665.USD","THNR","BK4533","LU0320765059.SGD","ELIS","LU2237438978.USD","LU2089984988.USD","LU0198837287.USD","LU0079474960.USD","GB00BDT5M118.USD","LU0943347566.SGD","LU1804176565.USD","SG9999014906.USD","SG9999013999.USD","LU1979441026.SGD","LU0234572021.USD","LU0114720955.EUR","LU2456880835.USD","LU1057294990.SGD","LU0109391861.USD","LU0058720904.USD","LU0203202063.USD","LU0683600562.USD","LU1551013425.SGD","LLYZ","LU1023059063.AUD","LU1988902786.USD","LU1868837300.USD","LU1366192091.USD","SGXZ57979304.SGD","OZEM","SGXZ31699556.SGD","IE00B1BXHZ80.USD","LU0820561818.USD","LU1280957306.USD","IE00BJJMRY28.SGD","LU2361045086.USD","LU0094547139.USD","LU1917777945.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2896262040.SGD","LU2462591350.SGD","IXJ","SG9999001176.SGD","LU0456855351.SGD","SG9999018865.SGD","SG9999017495.SGD","TMED","LU1232071149.USD","IE00B775H168.HKD","LU1323610961.USD","LU2264538146.SGD","LU0174119429.USD","LU1064131342.USD","LU2211815571.USD","LLY","LU1989771016.USD","LU2552382132.HKD","LU0122379950.USD","FTXH","LU0689472784.USD","LU1868836914.USD","LU0787776722.HKD","LU0823434740.USD","LU2168564495.EUR","LU0266013472.USD","LU1868836591.USD","LU2237443465.HKD","LU2471134796.USD","NVOX","LU0345770993.USD","LU0823434583.USD","IE00BKPKM429.USD","LU1623119135.USD","LU0158827781.USD","BK4581","LLYX","BK4532","IE00BK4W5L77.USD","LU0225283273.USD","IE0001KFT4U8.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183741843","title":"從GLP-1先行者到被禮來反超，諾和諾德如何一步步丟掉減重藥領先優勢","url":"https://stock-news.laohu8.com/highlight/detail?id=1183741843","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183741843?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 10:33","pubTimestamp":1785983625,"startTime":"0","endTime":"0","summary":"诺和诺德曾凭借Ozempic和Wegovy率先打开GLP-1减重药市场，并一度成为欧洲市值最高的上市公司。但随着产能不足、美国直销渠道布局偏慢以及研发管线对司美格鲁肽依赖较深，先发优势逐渐被削弱。与此同时，礼来凭借Zepbound、Mounjaro以及更丰富的下一代减重药管线实现反超。如今，诺和诺德正在通过组织调整、扩大产能和加快新品商业化重新追赶，而真正决定未来竞争格局的，仍是下一代产品能否重新建立差异化优势。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7ec85b2c1f723f3e05278a0cd609e815","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7ec85b2c1f723f3e05278a0cd609e815"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","NVOH","LLII","LLYZ","LLYX","LLY","NVOX","ELIS","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135937164","title":"金錢語錄：諾和諾德CEO談併購","url":"https://stock-news.laohu8.com/highlight/detail?id=1135937164","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135937164?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 01:49","pubTimestamp":1785952183,"startTime":"0","endTime":"0","summary":"“我不清楚那两家正试图互相接洽的竞争对手究竟有何需求，但我们目前看不到进行变革性并购的必要性。”——这是Ozempic生产商诺和诺德（Novo Nordisk）的首席执行官迈克·杜斯特德（Mike Doustdar）在接受《华尔街日报》采访时所言。此番言论针对的是近期《金融时报》的一篇报道，该报道称阿斯利康（AstraZeneca）与百时美施贵宝（Bristol Myers Squibb）曾就潜在合并事宜进行过商谈。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","NVO","BK4007","NVOH","THNR","NVOX","OZEM","PPH","BK4585","BK4532","LU0154236417.USD","LU1093756168.USD","IE00BKVL7J92.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657529184","title":"美銀首席執行官：公司每年為員工支出2.5億美元用於報銷GLP-1減重藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2657529184","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657529184?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 00:44","pubTimestamp":1785948240,"startTime":"0","endTime":"0","summary":"美银首席执行官布莱恩莫伊尼汉周三接受采访称，美国银行每年花费逾 2.5 亿美元，承担员工使用 GLP-1 减重药物的费用。根据莫伊尼汉给出的数据，美银每年为约 21.1 万名员工预留合计超 20 亿美元医疗预算；仅 GLP-1 药物一项，如今就占到全部医疗开支的约 13%。“我们在 GLP-1 药物上投入大约 2.5 亿美元甚至更多，而四五年前这项支出还是零。”这家全美资产规模第二大的银行，同时依托自身庞大的采购体量，与药企、药房福利管理机构谈判压低药价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-06/doc-inimhyac1066977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4144","OZEM","GLP","JDOC","NVOH","BK4590","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657998525","title":"相差百億美元！全球第一大藥王與第二大藥王銷售差距在拉大","url":"https://stock-news.laohu8.com/highlight/detail?id=2657998525","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657998525?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 22:54","pubTimestamp":1785941698,"startTime":"0","endTime":"0","summary":"礼来的替尔泊肽与诺和诺德的司美格鲁肽，在2025年分别成为全球销售额第一大、第二大药物，但这两大GLP-1药物之间的销售额差距在拉大。8月5日晚间，礼来公布的半年报显示，2026年上半年，替尔泊肽（降糖适应证产品Mounjaro和减重适应证产品Zepbound）合计收入达到276.93亿美元，同比大增近88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832918043.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832918043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BFSS7M15.SGD","LU1548497426.USD","BK4581","LU2456880835.USD","LU1291159041.SGD","GDOC","LU2106854487.HKD","SG9999013999.USD","THNR","LU2168564222.USD","LU0820562030.AUD","PJP","SGXZ57979304.SGD","BK4599","LU2237443382.USD","BK4516","LU2417539215.USD","LU2361045086.USD","ELIS","LU2756315664.SGD","SGXZ99366536.SGD","LU2089284900.SGD","LU0640476718.USD","LLYZ","LU2461242641.AUD","LU0096364046.USD","LU1629891620.HKD","SGXZ81514606.USD","SG9999014880.SGD","LU0320765059.SGD","LU2108987350.USD","LU0133085943.USD","LU0323591593.USD","TRUH","LU2237443622.USD","LU2265009873.SGD","LU1868837136.USD","LU0683600562.USD","LU1868837300.USD","LU2471134796.USD","LU2112291526.USD","SG9999018865.SGD","LU0174119429.USD","LU1061106388.HKD","NVOX","LU0943347566.SGD","IHE","LLYX","LU2324357040.USD","LU2471134879.HKD","PPH","LU0964807845.USD","BK4585","LU0097036916.USD","LU1551013342.USD","LU2237438978.USD","LU0787776722.HKD","IE00BJJMRY28.SGD","LU1868836757.USD","LU1804176565.USD","LU1093756168.USD","LU2746668461.USD","LU0094547139.USD","LU0210536198.USD","BK4533","LU0345770308.USD","LU2063271972.USD","LU2089984988.USD","SG9999014898.SGD","BK4007","NVO","LU0385154629.USD","IE00BK4W5L77.USD","LU1551013425.SGD","LU1366192091.USD","SG9999018857.SGD","ILDR","LU0079474960.USD","LU2360106947.USD","LU1974910355.USD","LU2237443895.HKD","SG9999015986.USD","HRTS","OZEM","GB00BDT5M118.USD","IE0009355771.USD","LU0061475181.USD","SGXZ51526630.SGD","LU0122379950.USD","LU2491050154.USD","LU1127390331.HKD","IE00B4JS1V06.HKD","LU1720051108.HKD","LU0353189680.USD","SG9999017495.SGD","FTXH","IE00BFTCPJ56.SGD","LU0106261372.USD","LU1093756325.SGD","VHT","IE00BKVL7J92.USD","LU0234572021.USD","LU0820561818.USD","LU0154236417.USD","IE00BJLML261.HKD","LU2028103732.USD","IE0004445239.USD","LU0354030438.USD","LU2211815571.USD","LU1069344957.HKD","LU1232071149.USD","LU0456855351.SGD","LU2023250504.SGD","LU2089283258.USD","LU2168564149.EUR","CANC","RXL","AGNG","WDNA","LU0471298694.HKD","IE00B7KXQ091.USD","JDOC","LU0471298777.SGD","LU1868836914.USD","LU2264538146.SGD","BK4532","IE0002141913.USD","XLV","LU2361044865.SGD","LU0198837287.USD","LU1917777945.USD","LU1623119135.USD","LU0823434740.USD","IE00BWXC8680.SGD","LU1280957306.USD","LU2552382058.USD","SG9999015978.USD","IE00BN29S564.USD","LU1035775433.USD","LU0238689110.USD","SG9999014914.USD","LU0889565916.HKD","IE00BFSS8Q28.SGD","LU2111349929.HKD","IE00B2B36J28.USD","IE0005OL40V9.USD","LU1057294990.SGD","IE00BKDWB100.SGD","LU0345770993.USD","LU2236285917.USD","MEDI","LU0316494557.USD","LU0672654240.SGD","IE00B1XK9C88.USD","LU2168563687.JPY","LU2357305700.SGD","IE00BJJMRX11.SGD","LU1983299246.USD","LU2237443465.HKD","ELIL","LU0109391861.USD","LU2491050071.SGD","LU2023250330.USD","LU1868836591.USD","LU1064131342.USD","LU1023059063.AUD","LU0708995401.HKD","LLII","LU2237443549.SGD","IE0004445015.USD","LU0417517546.SGD","IYH","IE00B4R5TH58.HKD","LU0203202063.USD","BK4534","LU0058720904.USD","LU0256863902.USD","LU1145028129.USD","LU1267930730.SGD","LU0882574055.USD","LU2213496289.HKD","LU2552382132.HKD","LU0225283273.USD","MEDX","IE0001KFT4U8.USD","LU1979441026.SGD","LU0256863811.USD","LU0266013472.USD","IE00BK4W5M84.HKD","IE00BKPKM429.USD","LU0786609619.USD","LU0823434583.USD","LU0320765992.SGD","LU2087625088.SGD","LU0006306889.USD","LU2271345857.HKD","LU2468319806.SGD","SG9999001176.USD","LU2746668974.SGD","LU2462157665.USD","CURE","LU0820561909.HKD","LU2023251221.USD","LU2471134523.USD","LU2491049909.HKD","SGXZ31699556.SGD","LU1323610961.USD","IE00BZ1G4Q59.USD","IE00B775H168.HKD","LU0203201768.USD","LU0353189763.USD","LU1814569148.SGD","LU0109394709.USD","LU0466842654.USD","LU2471134952.CNY","LU2602419157.SGD","LU0823416689.USD","LU2361044949.HKD","SG9999001176.SGD","NVOH","LU2756315318.SGD","TMED","LU2237443978.SGD","LU2168564065.EUR","FHLC","LU0289739699.SGD","SG9999015945.SGD","LU1712237335.SGD","LU1988902786.USD","LU0689472784.USD","LU0882574139.USD","LU1720051017.SGD","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU2750360641.GBP","LU2896262040.SGD","MHIP","LU2168564495.EUR","LU0158827948.USD","LU0158827781.USD","LU2750360997.AUD","LU0114720955.EUR","SG9999015952.SGD","IE00BJT1NW94.SGD","LU1989771016.USD","LLY","LU2462591350.SGD","SG9999014906.USD","IXJ","BK4588","LU2552382215.SGD","LU0354030511.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657528844","title":"二季度利潤亮眼股價卻下跌近6% 口服減重藥能撐起諾和諾德的中長期預期嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2657528844","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657528844?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:50","pubTimestamp":1785937800,"startTime":"0","endTime":"0","summary":"二季度利润超预期、上调全年指引，却遭遇美股下跌6%；口服GLP-1药物Wegovy商业化取得突破，但下一代核心CagriSema两次头对头败给礼来替尔泊肽。在千亿美元减肥药赛道，诺和诺德正经历从“霸主”到激烈博弈的转变，增长的希望与风险高度集中于口服GLP1这条路线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832855655.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832855655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4532","BK4599","BK4585","NVOH","PPH","NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","OZEM","BK4588","THNR","IE00BKVL7J92.USD","LU1093756168.USD","BK4007","NVOX","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657238540","title":"諾和諾德：海牙法院針對 Ceban 下達臨時禁令。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657238540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657238540?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:44","pubTimestamp":1785937442,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOX","BK4599","IE00BKVL7J92.USD","NVOH","THNR","BK4588","LU1093756168.USD","LU1093756325.SGD","NVO","BK4007","OZEM","BK4585","PPH","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657540463","title":"諾和諾德贏得荷蘭法院禁令，保護患者免受未經批准的非法複方司美格魯肽鼻噴霧劑的侵害。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657540463","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657540463?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:43","pubTimestamp":1785937380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756168.USD","LU0154236417.USD","NVOH","NVOX","OZEM","IE00BKVL7J92.USD","BK4599","PPH","BK4585","LU1093756325.SGD","BK4588","IE00BZ1G4Q59.USD","THNR","BK4532","NVO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547441","title":"國產藥加速追趕 減重明星賽道進入「群雄逐鹿」時代","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547441","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657547441?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:07","pubTimestamp":1785935232,"startTime":"0","endTime":"0","summary":"新华财经上海8月5日电2026年，我国“体重管理年”三年行动进入收官之年。当前，全民体重管理意识和技能显著提升，健康生活方式更加普及，部分人群体重异常状况得到改善。体重管理催生了减重经济。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832808212.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832808212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVOC","NVOX","RSPH","THNR","NVOH","JDOC","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657073541","title":"諾和諾德首席執行官：相較於注射劑，口服版 Wegovy 的市場需求之高，讓我們愈發感到意外。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657073541","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657073541?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 20:04","pubTimestamp":1785931485,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["OZEM","PPH","BK4007","IE00BKVL7J92.USD","LU1093756325.SGD","BK4532","THNR","BK4599","BK4588","LU1093756168.USD","NVOH","LU0154236417.USD","NVO","BK4585","NVOX","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657490745","title":"諾和諾德股價下跌6.8%，觸及盤中低點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657490745","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657490745?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 19:43","pubTimestamp":1785930191,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","NVOH","NVOX","OZEM","BK4007","NVO","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","LU1093756168.USD","PPH","THNR","BK4532","BK4585","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657003549","title":"諾和諾德：目前美國市場索馬魯肽注射劑Wegovy的價格走勢與我們年初啓動定價時一致。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657003549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657003549?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 19:42","pubTimestamp":1785930157,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0154236417.USD","NVOX","THNR","LU1093756325.SGD","OZEM","LU1093756168.USD","BK4599","NVOH","BK4588","BK4532","BK4585","IE00BKVL7J92.USD","PPH","BK4007","NVO","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657539549","title":"諾和諾德首席財務官表示：我們推進全公司轉型以實現80億丹麥克朗成本節約目標的進度，目前已超前於計劃。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657539549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657539549?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 19:23","pubTimestamp":1785929036,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","BK4599","BK4588","OZEM","NVOX","BK4532","THNR","BK4007","NVO","PPH","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0154236417.USD","BK4585","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510014","title":"諾和諾德股價跌勢擴大，目前跌幅已超5%，年初至今累計下跌10%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510014","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510014?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 18:06","pubTimestamp":1785924365,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVO","NVOH","LU0154236417.USD","PPH","THNR","BK4585","OZEM","NVOX","BK4007","LU1093756325.SGD","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4588","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657107295","title":"諾和諾德(NVO.US)首席執行官：我們將在資本市場日上詳細介紹如何加速早期資產和早期科學的推進。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657107295","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657107295?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 18:03","pubTimestamp":1785924200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LU1093756168.USD","THNR","BK4599","OZEM","LU0154236417.USD","NVOX","BK4532","BK4007","IE00BZ1G4Q59.USD","LU1093756325.SGD","PPH","BK4585","IE00BKVL7J92.USD","NVOH","NVO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}